| AKT | Protein kinase B |
| ALD | Alcoholic liver disease |
| AST | Aspartate transaminase |
| ATX | Autotaxin |
| AUROC | Area under the receiver operating characteristic |
| BMI | Body mass index |
| CCR | C-C chemokine receptors |
| CI | Confidence interval |
| ECM | Extracellular matrix |
| ER | Endoplasmic reticulum |
| ERK | RAS extracellular signal-regulated kinase |
| GCK | Glucokinase regulator |
| HCC | Hepatocellular carcinoma |
| HOMA | Homeostasis model assessment parameter |
| HR | Hazard ratio |
| HSC | Hepatic stellate cell |
| HSD17B13 | Hydroxysteroid 17β-dehydrogenase |
| IGF | Insulin-like growth factor |
| IGN | Intestinal gluconeogenesis |
| IKK | Inhibitor of nuclear factor-κB kinase |
| IL | Interleukin |
| IR | Insulin resistance |
| IRS | Insulin receptor substrate |
| JNK | c-Jun N-terminal kinase |
| JSG-NAFLD | Japan Study Group of NAFLD |
| LOXL2 | Lysyl oxidase-like 2 |
| LSM | Liver stiffness measurement |
| Mac-2bp | Mac-2 binding protein |
| MBOAT7 | Membrane bound O-acyltransferase domain- containing 7 |
| MMP | Matrix metalloproteinase |
| MRE | Magnetic resonance elastography |
| NAFLD | Nonalcoholic fatty liver disease |
| NASH | Nonalcoholic steatohepatitis |
| NF-κB | Nuclear factor-kappa B |
| NFS | NAFLD fibrosis score |
| OPN | Osteopontin |
| OR | Odds ratio |
| PDK | Phosphoinositide-dependent kinase |
| PI3K | Phosphatidylinositol 3-kinase |
| PNPLA3 | Patatin-like phospholipase domain containing 3 |
| SOCS | Suppressor of cytokine signaling |
| TAZ | Transcriptional coactivator with PDZ- binding motif |
| TEAD | TAZ/TEA domain |
| TGF-β | Transforming growth factor-β |
| T2DM | Type2 diabetes mellitus |
| TM6SF2 | Transmembrane 6 superfamily member 2 |
| TNF | Tumor necrosis factor |
| VCTE | Vibration-controlled transient elastography |
| WFA+-M2bp | Wisteria floribunda agglutinin-positive Mac-2-binding protein |